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a b s t r a c t
Ethnopharmacological relevance: Herbal medicine value chains have generally been overlooked com-
pared with food commodities. Not surprisingly, revenue generation tends to be weighted towards the
end of the chain and consequently the farmers and producers are the lowest paid beneﬁciaries. Value
chains have an impact both on the livelihood of producers and on the composition and quality of
products commonly sold locally and globally and consequently on the consumers. In order to understand
the impact of value chains on the composition of products, we studied the production conditions for
turmeric (Curcuma longa) and the metabolomic composition of products derived from it. We aimed at
integrating these two components in order to gain a better understanding of the effect of different value
chains on the livelihoods of some producers.
Materials and methods: This interdisciplinary project uses a mixed methods approach. Case studies were
undertaken on two separate sites in India. Data was initially gathered on herbal medicine value chains by
means of semi-structured interviews and non-participant observations. Samples were collected from
locations in India, Europe and the USA and analysed using 1H NMR spectroscopy coupled with
multivariate analysis software and with high performance thin layer chromatography (HPTLC).
Results: We investigate medicinal plant value chains and interpret the impact different value chains have
on some aspects of the livelihoods of producers in India and, for the ﬁrst time, analytically assess the
chemical variability and quality implications that different value chains may have on the products
available to end users in Europe. There are beneﬁts to farmers that belonged to an integrated chain and
the resulting products were subject to a higher standard of processing and storage.
By using analytical methods, including HPTLC and 1H NMR spectroscopy, it has been possible to
correlate some variations in product composition for selected producers and identify strengths and
weaknesses of some types of value chains. The two analytical techniques provide different and
complementary data and together they can be used to effectively differentiate between a wide variety
of crude drug powders and herbal medicinal products.
Conclusions: This project demonstrates that there is a need to study the links between producers and
consumers of commodities produced in so-called ‘provider countries’ and that metabolomics offer a
novel way of assessing the chemical variability along a value chain. This also has implications for
understanding the impact this has on the livelihood of those along the value chain.
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1. Introduction
Ethnopharmacological research has generally focused on herbal
starting materials and their composition and effects, or on the ﬁnal
products available to the consumer. There has been a limited focus
on the interconnectivities linking producers and consumers (Booker
et al., 2012).
On the other hand, global value chain analysis has been
commonly applied to food sectors, including tea, coffee and cocoa
(Kaplinsky, 2004; Gibbon and Ponte, 2005; Fullbright, 2008) but
little work has been undertaken in this area regarding medicinal
plants. Agricultural production is generally in developing coun-
tries, while the consumption is both in developing and developed
countries. Clearly such a usage impacts on public health, poten-
tially not only in a beneﬁcial but also detrimental way and it has a
direct relevance in the context of ethnopharmacology.
It is an important area for research since the production of high
value products is an emerging but poorly understood economic
activity within many developing countries, and particularly within
India and China, both with a long history of trading in such
commodities. According to the World Health Organisation (WHO),
world trade in herbal medicine was estimated at $83 Billion in
2008 (Robinson and Zhang, 2012).
Much of the trade in medicinal plants has been based within
national market systems. While global trade in high value pro-
ducts like spices and medicines has a long history, e.g. along the
spice route (Freedman, 2003), over the last 30 years international
trade has ﬂourished and a main thoroughfare of this trade exists
between Asia and Europe, the US and Australia.
While ethnopharmacology has historically focused on the
‘traditional’ uses in far away regions, it is now more and more
accepted that the complex interrelationship between producers
and consumers needs to be studied from a trans-disciplinary
viewpoint (Heinrich et al., 2011).
From a global perspective Europe has been leading the way in
supplying high quality herbal products, ﬁrst with diverse national
initiatives and also with the development of quality standards, for
example, in the European Pharmacopoeia and, more recently, with the
introduction of the EU-wide Traditional Herbal Medicinal Products
Directive (THMPD, 2004/24/EC) (European Parliament, C, 2004) which
requires well deﬁned minimal standards of quality and safety to be
assured before a product can be released onto the market. Therefore,
compared with food crops, medicinal plants may be more attractive
economically (Alam and Belt, 2009; Sharmin, 2004). However, the
European quality requirements for medicinal plants, plant extracts and
herbal medicinal products set a much higher entry bar than for foods
requiring more sophisticated inputs along the value chain.
The traceability of raw materials used in herbal medicines has
always been problematic. In Asia, it is common practice for plants
to be collected from the wild or cultivated on small farms and then
either stored, for sometimes long periods, sold in the local market,
or auctioned at one of the designated auction sites (Kala et al.,
2006; van de Kop et al., 2006; Alam and Belt, 2009). Middlemen
are usually involved in the supply of plant material to herbal
manufacturers and any information regarding the origin and
primary processing is mainly lost. An alternative to this approach
has been the implementation of vertically integrated value chains
(VIVCs) (Fig. 1), where contracts are made between (in our case
study) the farmer in Asia and the retailer in Europe.
A VIVC can be deﬁned as when ‘a lead organisation’ is responsible
for two or more intertwined steps of the manufacturing or value chain
process (Strategy-Train, 2009). This has advantages for the farmer in
that a premium is paid for the crop, and the order size and type of
crop grown can be well deﬁned in advance, allowing for an effective
planting and cultivation strategy to be developed. For the buyer, the
advantages include that the crop has better traceability, a price has
been agreed in advance and so market ﬂuctuations are not an issue,
and knowledge that good cultivation practice has been employed.
India was chosen as a research site as it is a fast developing country
with a long tradition of medicinal plant use. It has an established
herbal medicine manufacturing base and a thriving export market
(Polshettiwar, 2006).
In order to study these inter-relationships, metabolomics offers
some novel and bioscientiﬁcally robust opportunities. It provides
what has been called a 0holistic view0 of the metabolites of a set of
organisms (Kim et al., 2011) and has been used in a wide range of
research ﬁelds like plant biotechnology, ethnopharmacology, eco-
logical toxicology and plant physiology (e.g. Verpoorte et al., 2005;
Kim et al., 2011; Liu et al., 2011; Michl et al., 2011), and is ideally
suited for comparing large number of samples as one would
encounter them, for example, along a value chain. At the same
time it is a method which as such is not validated and needs to be
compared to a standard method like high performance thin layer
chromatography (HPTLC), widely used in the authentication and
quality control of herbal substances (Reich and Schibli, 2007).
Following an online survey, turmeric (Curcuma longa L. Zingi-
beraceae) was chosen as a suitable case study. Turmeric0s use as
both food and a medicine presents an opportunity to show how a
value chain may be different for a food and a drug and how
investing in quality can lead to genuine value addition. There are
concerns over the quality of material available commercially. It is
acknowledged that the chemical composition is variable and mis-
identiﬁcation of species and adulteration are frequently reported
problems (Govindarajan, 1980; Dixit et al., 2009). There are several
species that may be confused with Curcuma longa.
Curcuma aromatica Salisb. (wild turmeric) has been known to
be used as an additive in order to improve the colour of cultivated
Curcuma longa, which in turn raises its auction value, but clearly is
an adulteration. In an integrated chain there is less opportunity (or
necessity) for adulteration to take place as a price for the crop has
already been agreed. An analytical assessment should be able to
determine which products have been adulterated. Curcuma
aromatica does not contain bis-demethoxycurcumin found in
Curcuma longa.
Curcuma zanthorrhiza Roxb. (Javanese turmeric) is native to Indo-
nesia and is commonly found in HMPs in Europe. It is listed in the
British Pharmacopoeia. This species also lacks bis-demethoxycurcumin
and is chemically similar to Curcuma aromatica. Curcuma kwangsiensis
S.G. Lee and C.F. Liang is a Chinese species and favoured for use in
traditional Chinese medicine (TCM) products.
This has led to the key research questions of this paper:
 How can the variation of the product composition be deter-
mined analytically? And how does this inform the debate about
value chains of herbal medicines?
Fig. 1. The generic herbal medicine value chain.
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 Which methods are most useful? How does the information
derived from NMR spectroscopy – metabolomics differ from
that of HPTLC and how can these analytical tools be used best
to study the interconnectivities between producers and
consumers?
2. Methodology
2.1. Fieldwork in India
Two study sites were included, providing a contrast between
products that derive from a ‘buyers market’ approach, typically to
be found in India and compare these with products that have been
produced through a VIVC. We sampled raw materials and products
from each site and then compared them with other products that
are available to consumers in India, Europe and USA.
The ﬁrst case study examines a farm site near to Erode (Tamil
Nadu), producing material sold through middlemen at an auction
house. This case study represents the traditional route of supply
where the plant material is bought by any buyer for a multitude of
purposes, including being purchased by a local HMP manufactur-
ing unit, where once traded, the traceability of the material is
generally lost.
The second case study focuses on a farm site located near
Shimoga, Karnataka, a farm in a chain, vertically integrated to a
primary manufacturing site in Bangalore, and a secondary manu-
facturing site in the UK.
These farms provide a good comparison between an integrated
and non-integrated approach, organic and non-organic, and high
and low output, which allows for a wide angled view of the
current situation and broad evaluation of the available data.
Several factors were considered to be of prime importance
when choosing the sites:
 To be able to examine sites that had a large, established trade in
Turmeric: Tamil Nadu and Karnataka are major growing areas
for this crop and Erode is regarded as the main trading city in
southern India.
 It was important to visit the sites during times of productivity;
the busy period for turmeric production runs from November
to April and this is the period when the majority of harvesting,
drying, processing and trading takes place.
Fieldwork was conducted during a period of two months in
January and February 2012 and again in October and November
2012. Our core sample was composed of farmers, farm workers,
processors and market traders.
We used a case study approach employing semi-structured
interviews and non-participant observations. Semi-structured
interviews are useful in obtaining general and speciﬁc information
from a sample of the population and gaining a range of insights on
a speciﬁc issue. This methodology had advantages over a fully
structured approach in that it was less intrusive, encouraging two
way communication. It also provided data on the reasons behind
their answers (FAO, 1990). As previously outlined by Handley
(2012), observational methods offer an objective insight into what
people do rather than what they say they do. Thoughtful and
judicious use of observational methods provides one of the most
effective ways for understanding activities ‘in situ’.
2.2. Laboratory analysis
Throughout the ﬁeldwork stage of the project, commercial samples
were gathered from sites across India, USA and Europe. Samples taken
included ethanol extracts, aqueous extracts, powdered medicinal
products, food powders, powders used chieﬂy as cosmetics, whole
dried rhizomes and tubers and fresh rhizomes. These samples were
taken back to the UCL School of Pharmacy for analysis. Apart from the
vertically integrated chain samples and the fresh rhizomes, there is no
way of telling the true age of any of the HMP or market collected
samples due to the lack of documented traceability regarding storage
time.
We analysed the samples using 1H nuclear magnetic resonance
(NMR) spectroscopy and multivariate analysis software. The sam-
ples were grouped according to the product information accom-
panying each sample, e.g. the label information. The groupings
were validated through the use of authenticated reference mate-
rial and through the collection of a proportion of samples directly
from the cultivation site. For comparison, the samples were then
analysed ‘blind’ using HPTLC techniques. This analysis was not to
provide a direct comparison of sample metabolites, but to com-
pare the approaches. Therefore, different extraction solvents were
used, but to discover what information could be determined
regarding each sample using each analytical technique.
2.2.1. 1H NMR spectroscopy methods
2.2.1.1. Sample preparations for 1H NMR spectroscopy analysis. The
method for the extraction of plant samples was developed from a
method described by Kim and Verpoorte (2010). Initial
experiments were carried out using chloroform-D, and DMSO-D6
and methanol-D4 but it was found that DMSO-D6 was a better
extracting solvent because the 1H NMR spectra showed more
peaks in the 0–10 ppm range than with the other solvents tried.
Approximately 20 mg of all the samples were weighed into a
1.5 ml reaction tube and 1.0 ml of deuterated DMSO-D6 containing
0.05%TMS was added. The mixture was mixed on a rotary mixer
for 60 s, sonicated in an ultrasound bath for 15 min, and allowed to
stand for 1 h. The solutions were centrifuged for 10 min at
14,000 rpm. Eight hundred microlitres of the supernatant was
added to a 5 mm diameter NMR spectroscopy tube and the
samples were submitted for NMR analysis.
2.2.1.2. 1H NMR spectroscopy – metabolomic analysis. 1H NMR
spectra of the turmeric samples were recorded at temperature 298 K
on a Bruker Avance 500 MHz spectrophotometer (Bruker Analytik,
Rheinstetten, Germany) equipped with a 5 mm cyroprobe head
and operating at proton frequency of 500.13 MHz. The spectra
were acquired with 256 scans, requiring approximately 10 min
acquisition time.
The following parameters were used during the acquisition:
0.16 Hz/point, pulse width (PW)¼301 and relaxation delay¼1 s.
FIDs were Fourier transformed with LB¼0.30 Hz. The spectra were
referenced to the internal TMS peak. TOPSPIN version 1.3 software
was used for spectra acquisition and processing of the 1H NMR
spectra which were manually corrected for phase and baseline
distortions. The spectra were exported to Topspin Plot editor (3.5
Bruker) and thoroughly examined visually for appropriate refer-
ence peaks for the identiﬁcation of curcuminoids in the sample.
The 1H NMR spectra of all the samples were imported to the AMIX
software 3.5 and simpliﬁed by using the bucketing function. The
spectra in the range 0–12 ppm were divided into 301 buckets of
0.04 ppm. The residual solvent signals for DMSO (2.65–2.45 ppm)
and water (3.60–3.10 ppm) were excluded. This data was imported
to Microsoft EXCEL where the samples were re-labelled S1–S52.
The data was then imported to SIMCA, version 13.0 software, for
principal component analysis (PCA).
2.2.2. HPTLC methods
2.2.2.1. Sample preparations for HPTLC analysis. The method for the
extraction of plant samples was developed from a standardised
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method used at CAMAG laboratories based on a method of the
British Pharmacopoeia. Approximately 200 mg of all the samples
was weighed into a 10 ml reaction tube and 4.0 ml of solvent was
added (methanol for curcuminoids, toluene for determination of
essential oils and water for sugars). The mixture was mixed on a
rotary mixer for 60 s and shaken for 20 min. The solutions were
centrifuged for 10 min at 14,000 rpm. The supernatant solution
was transferred to a vial and the samples were submitted for
HPTLC analysis.
2.2.2.2. HPTLC analysis. HPTLC was carried out using Merck HPTLC
glass plates 2010 cm, Si 60 F254.
HPTLC Plates: Samples were applied using the CAMAG Auto-
matic TLC Sampler 4. Three developing systems were used, for
curcuminoid determination, (Toluene, acetic acid 4:1), for sugars
(Acetonitrile: acetone: water 40:40:20) and for essential oils
(Dichloromethane). The lab temperature was 23 1C and tank
humidity within the developing tank was controlled at 33%. The
developed plates were derivatised by dipping with anisaldehyde
reagent (curcuminoid and essential oil systems) and aniline-
diphenylamine-phosphoric acid for sugars, using a CAMAG chro-
matogram immersion device III and heated to 100 1C on a plate
heater. The plates were inspected using a CAMAG visualiser under
white light and at UV 366 nm, photographed and uploaded into
the computer software (WinCats).
3. Results and discussion
3.1. Fieldwork in India
Two farm sites were compared in southern India. The ﬁrst site
in Erode, Tamil Nadu grows sugar cane as its main crop and
turmeric as a secondary crop. Turmeric suffers from leaf rot and
thin rhizomes and so different proprietary herbicides, fungicides
and pesticides are used together with fertilisers including potash,
urea and manure. After harvesting, the turmeric is boiled using a
mobile steam generator which is hired from a third party. The
boiling step is used to decrease microbial load and help to remove
water from the roots and rhizomes. Following the boiling step, the
material is dried in the sun for 20 days before polishing. The
polishing gives the product a more intense yellow colour, making
it more attractive to buyers. Both the root and the rhizome are
used and both can be re-planted. The root tends to be used more
for use in paints and dyes and for cosmetic purposes.
In 2011 the auction price of turmeric was 18,000 rupees (US$
280) per quintal (100 kg) in 2012 it had fallen to 4000 rupees (US$
60) per quintal. At this price it is difﬁcult for farmers to recoup
their costs and so they may choose to store the crop until prices
rise. At the government regulated market, they sell about 2000
bags of turmeric per day at about 4000 rupees per bag, depending
on quality. Samples are displayed for buyers prior to the auction
for organoleptic inspection and subsequently the buyers will bid
for each lot. Buyers are generally aware (through the available
documentation), from which farms the lots are sourced, but little
information regarding the cultivation and processing methods is
provided. The auction market receives 2% of the sale price as
commission. Farmers who do not want to sell their product
immediately, send their harvest to one of the approximately 350
storage units, situated in Erode. Turmeric can be stored in a facility
such as this for up to ﬁve years. When the crop is sold, the storage
unit owner also receives 2% as commission. The turmeric is stored
in jute sacks and evidence of weevil infestation and fungal moulds
were evident.
The second case study is a 30 acre farm set in 450 acres of
forest that is managed by a conservancy trust. The farm has been
certiﬁed organic since 2004. The farm cultivates Areca catechu L.
(Arecaceae) as a main crop and medicinal herbs are grown as
secondary crops. The farm also produces food crops: chili, allspice,
cinnamon, nutmeg, pepper, bananas, coconut and ginger, which
are sold at local markets.
Following harvesting, the crops are cleaned by hand,
washed using a tiered system, and then drained and dried,
initially in a drying room, before being laid out in the sun on
plastic sheets for further drying. At this farm the turmeric
rhizome is supplied to a primary processing company in
Bangalore. The company in Bangalore has a contract with the
farmer and does not generally buy material from market
sources. The farmer receives a 10–40% premium for spices,
foods and medicinal plants, above the market price because of
the complexity of cultivation and the good agricultural practice
(GAP) processes employed (speciﬁcally for ginger 30–40%,
turmeric 10%, coffee 10%, pepper 20%, white pepper 30%). The
premium is adjusted depending on the conventional market
price and so the farmer receives the agreed price for their crop
irrespective of the market price in a similar fashion to the
Fig. 2. Scores plot showing samples grouped according to species, PC1 vs PC2.
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Fairtrades scheme. After cutting and grinding the turmeric is
shipped to the UK for secondary manufacture.
3.2. Laboratory analysis
3.2.1. 1H NMR spectroscopy
The samples were analysed using 1H NMR spectroscopy
coupled with SIMCA multivariate analysis software and by HPTLC.
Using both of these techniques it was possible to order the
products into different groups. With the SIMCA software the
groups were separated with reference to species (Fig. 2) and to
dosage form/morphology (Fig. 3). Using this method it was
possible to differentiate three separate species based on their
principal component variability: Curcuma longa L., Curcuma
aromatica Salisb., Curcuma zanthorrhiza Roxb., and a range of
different dosage forms, comprising ethanolic extracts, a super
critical ﬂuid extract, aqueous extracts, powdered medicinal drugs,
powders used as food, mixed powder and extract products, dried
cut rhizomes, whole dried rhizomes and fresh turmeric rhizomes.
The contribution plot provides information on how PCA sepa-
rates the samples based on the differences of the intensity of
compounds at particular chemical shifts i.e. it describes where the
main variability in chemical composition occurs and the software
enables us to demonstrate these differences graphically. Compar-
ing an ethanol extract (sample 1), against the average for all
samples, sample 1 is higher in the chemical shift regions asso-
ciated with curcuminoids (6–10 ppm) but lower in the carbohy-
drate region (typically 3–6 ppm) and essential oils/fatty acid
region (typically 0.4–3 ppm) (Fig. 4).
PCA was able to differentiate four different species but the
initial analysis failed to differentiate Curcuma aromatica and
Curcuma zanthorrhiza satisfactorily (Fig. 2). However, when the
powder samples were analysed without the extracts, the PCA
differentiated them more effectively (Fig. 5). In Fig. 2, sample
5 appeared to be grouped with the Curcuma longa groupings and
in Fig. 3, sample 5 was grouped with the aqueous extracts,
suggesting that it was an aqueous extract of Curcuma longa.
However, this was not concordant with the product information
that was held on this product. It was observed in the contribution
 
Fig. 3. Scores plot showing samples grouped according to form, PC1 vs PC2.
Fig. 4. Contribution plot showing the metabolite differences between sample 1, an ethanol extract and the group average.
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plot (Fig. 4) that sample 5 was high in the carbohydrate region,
consistent with high sugar content. Subsequent HPTLC analysis
conﬁrmed that this was not an aqueous extract and was not
Curcuma longa as the PCA suggested (see Fig. 9).
The metabolite variability between species was chieﬂy in the
curcuminoid region (in Curcuma aromatica and Curcuma zanthorrhiza,
bis-demethoxy curcumin was absent, a phenomenon conﬁrmed by
HPTLC) and variation was also observed in the lower range of
chemical shift where one would expect to see essential oils (Fig. 6).
One reported difference between Curcuma longa and Curcuma
aromatica/Curcuma zanthorrhiza is the absence of tumerone in the
later species, the essential oil which gives Curcuma longa its dis-
tinctive aromatic smell. This was conﬁrmed by running a tumerone
reference standard. Sample 19 was interesting as although sold as
Curcuma longa it appeared to be contaminated with Curcuma
aromatica or Curcuma zanthorrhiza (Figs. 5 and 9).
Curcuma aromatica samples were not well separated from
Curcuma zanthorrhiza samples. The curcuminoid composition
between Curcuma zanthorrhiza and Curcuma aromatica is not a
major variable and so in order to ﬁnd differences between these
two species it was necessary to examine different principal
components. A pattern was observed between the species and
samples 49–52 were particularly well grouped (Fig. 7). These four
samples came from the same geographical location. Although
sample 2 was labelled as complying with the BP and the company
claimed it was Curcuma zanthorrhiza, our data suggests that it was
more similar to the metabolite proﬁle of Curcuma aromatica.
We compared sample 47 to an ethanolic turmeric extract
(sample 1, Fig. 8) where we observed that sample 47 was far
lower in the curcuminoid region but higher in the essential oil
region. This may be a result of the high temperature processing
employed in the extraction process leading to the loss of volatile
compounds. Consequently, sample 47 may be richer in these
compounds as it has been collected fairly soon after harvesting
and has not been subjected to high temperature processing. Direct
comparison with the tumerone reference standard conﬁrmed that
sample 47 was relatively high in this compound.
3.2.2. HPTLC analysis
The samples were analysed blind by HPTLC in order to determine
what additional or different information could be found.
In Fig. 9, group 1 includes Curcuma aromatica and Curcuma
zanthorrhiza and group 2 consisted of Curcuma longa. We observed
Fig. 5. Scores plot comparing all powders, roots and rhizomes, grouped by species, PC1 vs PC2.
Fig. 6. Contribution plot showing where the main differences in metabolite composition between Curcuma longa and Curcuma zanthorrhiza.
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that bis-demothycurcumin (Rf 0.18) was only present in Curcuma
longa. Group 3 are the ethanolic/SCF extracts, aqueous extracts and
some unknown products. We also observed that group 1 exhibited
strong zones at Rf 0.58 and at Rf 0.82. These zones were observed
faintly in some of the Curcuma longa samples indicating possible
contamination from other species.
Sample 48 (group 3), a SCF extract, appeared to contain more
compounds than the other extracts. The samples in the last three
tracks were aqueous extracts and it was observed that no
curcuminoids or essential oils were detected. Sample 23 was
unusual in that it was an aqueous extract but contained curcumi-
noids. Sample 19 was sold as turmeric but was likely to be
Fig. 7. Scores plot showing differentiation of Curcuma aromatica and Curcuma zanthorrhiza, PC4 vs PC5.
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Fig. 9. Derivatised plate under white light. Mobile phase toluene, acetic acid 4:1 (curcuminoid determination).
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Curcuma aromatica or Curcuma zanthorrhiza. Sample 34 a TCM
product appeared different to other Curcuma longa chromato-
grams and may possibly be Curcuma kwangsiensis S.G. Lee and
C.F. Liang.
HPTLC was also used to determine if there were any differences
between samples that were sold as fresh rhizomes, samples
obtained through the integrated chain and those that had been
boiled, dried, polished and stored (the traditional method of
processing). Our ﬁrst hypothesis was that the samples obtained
through the integrated chain would have a metabolite proﬁle that
was closer to that of a fresh rhizome as the boiling, sun-drying,
polishing and storing steps were not used. Our second hypothesis
was that samples obtained through the traditional route may be
adulterated with Curcuma species other than Curcuma longa.
In Fig. 10, we observed that more compounds were present in
the freshest samples 38, 39 and 40. These were fresh rhizomes
that had not been boiled or dried. The integrated chain samples 47,
12 and 13 displayed a strong zone at Rf 0.25 which was also
observed for samples 38, 39 and 40. There was also a stronger
zone for the integrated chain samples and the fresh rhizomes at Rf
0.83. Sample 19 displayed a different pattern, having an extra
zone at Rf 0.65 and the bis-demethoxy curcumin zone at Rf 0.2
was missing (consistent with Curcuma aromatica and Curcuma
zanthorrhiza) indicating that this sample was not Curcuma longa.
In the HPTLC analysis of the essential oil system sample 19
stood out as being different from the rest of the group and was
likely to be Curcuma aromatica (Fig. 11). Sample 32 was a polished
rhizome from Erode and exhibited a band at Rf 0.5 indicating
possible adulteration with Curcuma aromatica. Sample 47 (track 2)
showed a strong zone at Rf 0.86 that was also observed with the
fresh rhizome samples.
4. General discussion
This research both has implications in the context of devel-
oping analytical (metabolomic) methods and for the use of
such techniques in understanding the interconnectivities of
producers and consumers. This has been done in the context of
comparing two analytical techniques, 1H NMR spectroscopy
and HPTLC, and assessing their relative strengths and weak-
nesses in connection with the analytical investigation of herbal
value chain products (see Table 1).
Both techniques were shown to be useful, but clearly, the
metabolomic analysis provided a sharper picture. As is generally
the case quality assurance needs to be developed for each
botanical drug and, therefore, turmeric is a speciﬁc example. As
we show below, it is the combination of these two methods which
has enabled us to understand both the general variability and the
speciﬁc differences between products.
For example, a low price for cultivated turmeric can force
farmers to store rather than sell (Booker et al., unpublished) and
this storage can be detrimental to the product as shown by the
comparison with the fresh rhizome samples. In the HPTCL and in
the 1H NMR spectroscopy it was observed that adulteration with
other species was a problem. Sample 19, sold as Curcuma longa
was determined to be Curcuma aromatica and sample 32, was
Curcuma longa clearly adulterated with Curcuma aromatica. Con-
versely, we have hypothesised that by establishing a well-managed
and well monitored vertically integrated value chain, end-companies
can exert a degree of control over processes and procedures that can
lead to a better-quality product. Samples obtained from the integrated
chain are more similar in composition to the fresh rhizomes tested
and free of contamination by other species
Fig. 10. Derivatised plate under UV 366 nm. Mobile phase toluene, acetic acid 4:1 (curcuminoid determination).
Fig. 11. Derivatised plate under UV 366 nm. Mobile phase dichloromethane (essential oil determination).
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As with other botanical drugs, traditional methods of cultivat-
ing and selling Curcuma longa can lead to adulteration with
incorrect Curcuma species. In addition, we have shown that some
of the sampled products, speciﬁcally the aqueous extracts, contain
almost no compounds that would generally be regarded as
therapeutically relevant or beneﬁcial. In our study we have
observed and measured how some products have different che-
mical characteristics to others, how some are different species,
different extracts and different potencies.
Only two of the medicinal quality Curcuma longa products
differ from the mass of ground turmeric available as a food
ingredient (based on both 1H NMR spectroscopy and HPTCL
data). One of these is a Chinese medicinal product and one is
from the integrated chain. The 1H NMR spectroscopy and HPTLC
data suggest that this is linked to variability in the chemical
composition of the essential oil (e.g. concentration of tumerone,
zingiberene). It is these more volatile compounds that are
likely to be lost during long term storage or due to the heat
caused in the traditional grinding process and this data supports
the traditional Indian view that the product should be used
within three months (Booker, 2012; unpublished ﬁeldwork
interviews).
Curcuma longa is an important medicinal and spice plant in
terms of its economic signiﬁcance, and usage within Europe and it
has potential as a licensed herbal medicinal product. The quality
differences and problems that are inherent within the turmeric
market help us to understand better the inﬂuence of quality
standards on the value chain and how a product may be prone
to adulteration, especially when lacking suitable controls and
without a vertically integrated system in place.
For the farmers and primary processors, developing and
implementing working practices that conform to international
requirements is a priority. If high quality raw materials can be
produced for the export market, this may lead to a shift in
equity towards the beginning stages of the value chain. More-
over, by forming partnerships and alliances with well-
established European companies, small farmers may expect
greater beneﬁts in terms of governance, training and supply of
essential inputs.
EU and WHO guidelines on GAP and Collection Practice (GACP)
stipulate that the production of a HMP of acceptable quality begins
with the harvest of the starting material. In the global pharma-
ceutical industry the quality of raw materials has been an
important factor for many years but in the paradigm of traditional
medicines, the focus has been chieﬂy on the end stages of supply,
with companies investing heavily into packaging, marketing and
advertising and other strategies that add value to the ﬁnished
product. The source and quality of the plant material has in many
instances been largely ignored, a problem highlighted in detail in
this study.
5. Conclusion and future work
In this study we used two analytical tools, 1H NMR spectro-
scopy and HPTLC, in order to understand the composition and
quality of herbal medicinal products along value chains. Both
methods provide different and complementary data and together
they can be used as tools to differentiate between a wide variety of
crude drug powders and herbal medicinal products. 1H NMR
spectroscopy coupled with multivariate analysis provides a quick
method of separating different samples but is sometimes fooled by
multi-component products or by the addition of excipients.
Coupling with HPTLC helps to avoid this pitfall and together the
two techniques provide a clear picture of sample composition,
offering new ways to understand local livelihoods and the fast
developing market links of ethnopharmacological commodities.
These analytical data are interpreted in the context of existing
value chains for turmeric. Turmeric medicinal product samples
obtained from within a vertically integrated value chain show a
closer resemblance to fresh samples of turmeric rhizome with
respect to their metabolite content than samples obtained from
the general market. Samples of turmeric obtained from a non-
integrated chain have shown to be contaminated with different
Curcuma species other than Curcuma longa. Most of the products
sold as aqueous extracts contained little trace of compounds that
were present in the powder and that would generally be regarded
as quality indicators, some contained polysaccharides but the
HPTLC analysis conﬁrmed that others only contained simple
sugars. Future work should focus on isolating and identifying
those compounds that were present only in the fresh samples of
turmeric and in the vertically integrated medicinal product. There
still are some conﬂicting results regarding the differences in chemical
composition of Curcuma aromatica and Curcuma zanthorrhiza and
how effectively 1H NMR spectroscopy or HPTLC can separate these
species and we are currently conducting further research in this area.
This study also provides a proof-of-concept for using combined
analytical techniques in the context of value chains of herbal
medicines and food supplements. These analytical techniques
have shown to be effective platforms for the rapid and accurate
determination of plant and plant product composition and future
studies should focus on their further development and reﬁnement
using them not only as a quality assurance tool at the end of a
value chain, but as a method to improve the production and
supply of such globalised commodities.
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Table 1
Comparison of key strengths and weaknesses of 1H NMR spectroscopy and HPTLC.
1H NMR HPTLC
Equipment expensive Equipment relatively cheap
High throughput technique with sample preservation High throughput technique with sample preservation
One system needed to view entire range of extractable metabolites Three systems needed to view entire range of extractable
metabolites
Multivariate analysis is able to group the samples according to the metabolite composition Grouping of samples is achieved manually by visual
inspection
Multivariate analysis can be confounded by multi-ingredient samples leading to errors in groupings Separate systems and visual inspection reduces grouping
errors
Manipulation of data allows for individual samples to be compared in detail against other samples or to
the whole group
Comparisons are generally achieved visually
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Appendix A. Supporting information
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.jep.2013.12.042.
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